Incidence patterns of soft tissue sarcomas, regardless of primary site, in the Surveillance, Epidemiology and End Results program, 1978-2001: An analysis of 26,758 cases

International Journal of Cancer

Volumn 119, Issue 12, 2006, Pages 2922-2930

  Toro, Jorge R ^a,d   Travis, Lois B ^a   Hongyu, Julian Wu ^b   Zhu, Kangmin ^b   Fletcher, Christopher D M ^c   Devesa, Susan S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiosarcoma; Dermatofibrosarcoma; Incidence; Leiomyosarcoma; Liposarcoma; Malignant fibrous histiocytoma; Rhabdomyosarcoma; SEER; Soft tissue sarcomas; WHO

Indexed keywords

AFRICAN AMERICAN; ANGIOSARCOMA; ARTICLE; CANCER INCIDENCE; CELL DIFFERENTIATION; DERMATOFIBROSARCOMA PROTUBERANS; EUROPEAN AMERICAN; HUMAN; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALIGNANT FIBROUS HISTIOCYTOMA; PRIORITY JOURNAL; RACE DIFFERENCE; RHABDOMYOSARCOMA; SKIN CANCER; SOFT TISSUE SARCOMA; UTERUS CANCER;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; DERMATOFIBROSARCOMA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMANGIOSARCOMA; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; INCIDENCE; LIPOSARCOMA; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RHABDOMYOSARCOMA; SARCOMA; SEX FACTORS; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS; UNITED STATES; UTERINE NEOPLASMS;

EID: 33751585501     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22239     Document Type: Article

References (59)

1. Zahm SH, Tucker MA, Fraumeni JF, Jr. Soft tissue sarcomas. In: Schottenfeld D, Fraumeni JF, Jr, eds. Cancer epidemiology and prevention, 2nd edn. New York: Oxford University Press, 1996. 984-99.
2. Zahm SH, Fraumeni JF, Jr. The epidemiology of soft tissue sarcoma. Semin Oncol 1997;24:504-14.
3. Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of tumors: pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press, 2002.
4. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L. SEER cancer statistics review, 1975-2001. http://seer.cancer.gov/csr/1975_2001/. Bethesda, MD: National Cancer Institute, 2004.
5. Storm HH. Cancers of the soft tissues. Cancer Surv 1994;19/20:197-217.
6. Ross JA, Severson RK, Davis S, Brooks JJ. Trends in the incidence of soft-tissue sarcomas in the United States from 1973 through 1987. Cancer 1993;72:486-90.
7. Eriksson M, Hardell L, Adami HO. Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. J Natl Cancer Inst 1990;82:1785-6.
8. Eriksson M, Hardell L, Berg NO, Moller T, Axelson O. Soft-tissue sarcomas and exposure to chemical substances: a case-referent study. Br J Ind Med 1981;38:27-33.
9. Karlsson P, Holmberg E, Samuelsson A, Johansson KA, Wallgren A. Soft tissue sarcoma after treatment for breast cancer - a Swedish population-based study. Eur J Cancer 1998;34:2068-75.
10. McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Parmley RT, DiCarlo FJ, Chadwick EG, Murphy SB. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 1995;5:332:12-8.
11. Weiss RA, Whitby D, Talbot S, Kellam P, Boshoff C. Human herpesvirus type 8 and Kaposi's sarcoma. J Natl Cancer Inst Monogr 1998;51-4.
12. Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 1998;90:606-11.
13. Hauben EI, Arends J, Vandenbroucke JP, van Asperen CJ, Van Marck E, Hogendoorn PC. Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma. Eur J Hum Genet 2003;11:611-8.
14. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer 1986;53:661-71.
15. Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkala E, Sistonen P, Herva R, Aaltonen LA. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 2001;98:3387-92.
16. Borden EC, Baker LH, Bell RS, Bramwell V, Demetri GD, Eisenberg BL, Fletcher CD, Fletcher JA, Ladanyi M, Meltzer P, O'Sullivan B, Parkinson DR, Pisters PW, Saxman S, Singer S, Sundaram M, van Oosterom AT, Verweij J, Waalen J, Weiss SW, Brennan MF. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res 2003;9:1941-56.
17. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2003 Sub (1973-2001). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch (released April 2004, based on the November 2003 submission).
18. Fritz A, Percy C, Jack A, Kanagaratnam S, Sobin L, Parkin DM. International Classification of Diseases for Oncology, 3rd edn. Geneva: World Health Organization, 2000.
19. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Cancer Surveillance Series: trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002;94:1204-10.
20. Surveillance Research Program, National Cancer Institute. SEER*Stat software (www.seer.cancer.gov/seerstat), version 6.1.4. Last accessed November 22, 2005.
21. Devesa SS, Donaldson J, Fears T. Graphical presentation of trends in rates. Am J Epidemiol 1995;141:300-4.
22. Sherman ME, Carreon JD, Lacey JV Jr, Devesa SS. Impact of hysterectomy on endometrial carcinoma rates in the United States. J Natl Cancer Inst 2005;97:1700-2.
23. Miettinen OS, Nurminen M. Comparative analysis of two rates. Stat Med 1985;4:213-26.
24. Zaki A, Mettlin C. Soft tissue sarcomas in whites and blacks living in the United States of America. J Surg Oncol 1992;50:130-3.
25. Polednak AP. Incidence of soft-tissue cancers in blacks and whites in New York state. Int J Cancer 1986;38:21-6.
26. Harms D. Soft tissue sarcomas in the Kiel Pediatric Tumor Registry. Curr Top Pathol 1995;89:31-45.
27. Caillaud JM, Gerard-Marchant R, Marsden HB, van Unnik AJ, Rodary C, Rey A, Flamant F. Histopathological classification of childhood rhabdomyosarcoma: a report from the International Society of Pediatric Oncology pathology panel. Med Pediatr Oncol 1989;17:391-400.
28. Newton WA Jr, Soule EH, Hamoudi AB, Reiman HM, Shimada H, Beltangady M, Maurer H. Histopathology of childhood sarcomas, intergroup rhabdomyosarcoma studies I and II: clinicopathologic correlation. J Clin Oncol 1988;6:67-75.
29. Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? a critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992;16:213-28.
30. Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol 2001;14:595-603.
31. Gaffney EF, Dervan PA, Fletcher CD. Pleomorphic rhabdomyosarcoma in adulthood. Analysis of 11 cases with definition of diagnostic criteria. Am J Surg Pathol 1993;17:601-9.
32. Barr FG, Galili N, Holick J, Biegel JA, Rovera G, Emanuel BS. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet 1993;3:113-7.
33. Yang P, Grufferman S, Khoury MJ, Schwartz AG, Kowalski J, Ruymann FB, Maurer HM. Association of childhood rhabdomyosarcoma with neurofibromatosis type I and birth defects. Genet Epidemiol 1995;12:467-74.
34. Korf BR. Diagnosis and management of neurofibromatosis type 1. Curr Neurol Neurosci Rep 2001;1:162-7.
35. Watson J, Depasquale K, Ghaderi M, Zwillenberg S. Nevoid basal cell carcinoma syndrome and fetal rhabdomyoma: a case study. Ear Nose Throat J 2004;83:716-8.
36. Ruymann FB, Maddux HR, Ragab A, Soule EH, Palmer N, Beltangady M, Beltangady M, Gehan EA, Newton WA, Jr. Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children's Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children's Cancer Study Group, and the Pediatric Intergroup Statistical Center). Med Pediatr Oncol 1988;16:33-9.
37. Spitsbergen JM, Tsai HW, Reddy A, Miller T, Arbogast D, Hendricks JD, Bailey GS. Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N′-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol Pathol 2000;28:716-25.
38. Toth B, Patil K, Erickson J, Gannett P. Carcinogenesis by benzenediazonium sulfate in mice. Vivo 1998;12:379-82.
39. Zaloudek C, Norris HJ. Mesenchymal tumors of the uterus. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract, 4th edn. New York: Springer-Verlag, 1994.487-528.
40. Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA. Hysterectomy surveillance-United States, 1994-1999. MMWR 2002;51:1-8.
41. Easterday CL, Grimes D, Riggs JA. Hysterectomy in the United States. Obstet Gynecol 1983;62:203-12.
42. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994;83:549-55.
43. Dicker RC, Scally MJ, Greenspan JR, Layde PM, Ory HW, Maze JM, Smith JC. Hysterectomy among women of reproductive age. JAMA 1982;248:323-7.
44. Sattin RW, Rubin GL, Hughes JM. Hysterectomy among women of reproductive age, United States, updated for 1979-1980. MMWR CDC Surveill Summ 1983;32:1SS-7SS.
45. Kelley TW, Borden EC, Goldblum JR. Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study. Appl Immunohistochem Mol Morphol 2004;12:338-41.
46. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 1996;41:483-90.
47. Schwartz SM, Weiss NS, Daling JR, Gammon MD, Liff JM, Watt J, Lynch CF, Newcomb PA, Armstrong BK, Thompson WD. Exogenous sex hormone use, correlates of endogenous hormone levels and the incidence of histologic types of sarcoma of the uterus. Cancer 1996;77:717-24.
48. Wysowski DK, Honig SF, Beitz J. Uterine sarcoma associated with Tamoxifen use. N Engl J Med 2002;346:1832-3.
49. Wickerham DL, Fisher B, Wolmark N, Bryant J, Costantino J, Bernstein L, Runowicz CD. Association of tamoxifen and uterine sarcoma. J Clin Oncol 2002;20:2758-60.
50. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459-65.
51. Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre JM, Terrier-Lacombe MJ, Mandahl N, Craver RD, Blin N, Sozzi G, Turc-Carel C, O'Brien KP, Kedra D, Fransson I, Guilbaud C, Dumanski JP. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma: Nat Genet 1997;15:95-8.
52. Evans HL. Liposarcoma: a study of 55 cases with a reassessment of its classification. Am J Surg Pathol 1979:507-23.
53. Sreekantaiah C, Karakousis CP, Leong SP, Sandberg AA. Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer 1992;69:2484-95.
54. Aman P, Ron D, Mandahl N, Fioretos T, Heim S, Arheden K, Willen H, Rydholm A, Mitelman F. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer 1992;5:278-85.
55. Crozat A, Aman P, Mandahl N, Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993:17;363:640-4.
56. Olofsson A, Willen H, Goransson M, Engstrom K, Meis-Kindblom JM, Stenman G, Kindblom LG, Aman P. Abnormal expression of cell cycle regulators in FUS-CHOP carrying liposarcomas. Int J Oncol 2004;25:1349-55.
57. Dal Cin P, Kools P, Sciot R, De Wever I, Van Damme B, Van de Ven W, Van den Berghe H. Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet 1993;68:85-90.
58. Pedeutour F, Forus A, Coindre JM, Berner JM, Nicolo G, Michiels JF, Terrier P, Ranchere-Vince D, Collin F, Myklebost O, Turc-Carel C. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 1999;24:30-41.
59. Szymanska J, Tarkkanen M, Wiklund T, Virolainen M, Blomqvist C, Asko-Seljavaara S, Tukiainen E, Elomaa I, Knuutila S. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer 1996; 15: 89-94.